HOLLISTON, Mass.--(BUSINESS WIRE)--March 6, 2006--Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of scientific instruments and apparatus used for drug discovery research, announced today that George Uveges has been appointed to serve on the Board effective as of the day after the Company files its Annual Report on Form 10-K for the fiscal year ended December 31, 2005 with the Securities and Exchange Commission. Mr. Uveges will serve on the Audit Committee of the Board effective as of the same day his appointment to the Board is effective.
